Bradley N. Rotter
Direttore/Membro del Consiglio presso Sequella, Inc.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Carol A. Nacy | M | 76 |
Sequella, Inc.
 Sequella, Inc. Pharmaceuticals: MajorHealth Technology Sequella, Inc. develops antibiotic drugs resistant to bacterial, fungal, and parasitic infections. It offers product for Mycobacterium tuberculosis, Helicobacter pylori, Clostridium difficile, Nontuberculous mycobacteria, Trypanosomes, and fungal infections. The company was founded by Carol A. Nacy and Leo Einck in 1997 and is headquartered in Rockville, MD. | 27 anni |
| William K. Hoskins | M | 89 |
Sequella, Inc.
Sequella, Inc. Pharmaceuticals: MajorHealth Technology Sequella, Inc. develops antibiotic drugs resistant to bacterial, fungal, and parasitic infections. It offers product for Mycobacterium tuberculosis, Helicobacter pylori, Clostridium difficile, Nontuberculous mycobacteria, Trypanosomes, and fungal infections. The company was founded by Carol A. Nacy and Leo Einck in 1997 and is headquartered in Rockville, MD. | - |
| Lawrence Miller | M | - |
Sequella, Inc.
Sequella, Inc. Pharmaceuticals: MajorHealth Technology Sequella, Inc. develops antibiotic drugs resistant to bacterial, fungal, and parasitic infections. It offers product for Mycobacterium tuberculosis, Helicobacter pylori, Clostridium difficile, Nontuberculous mycobacteria, Trypanosomes, and fungal infections. The company was founded by Carol A. Nacy and Leo Einck in 1997 and is headquartered in Rockville, MD. | - |
| Don Reiman | M | - |
Echelon Group, Inc.
 Echelon Group, Inc. Investment ManagersFinance Echelon Group, Inc. provides investment advisory services. It offers employee benefits, retirement and financial planning, investment management, and additional services. The company was founded by Don Reiman in 2004 and is headquartered in Idaho Falls, ID. | 20 anni |
| Jason Turner | M | - |
Entanglement, Inc.
 Entanglement, Inc. Information Technology ServicesTechnology Services Entanglement, Inc. is an early-stage deep technology advanced and quantum computing private company that provides commercial access to diverse advanced computing systems for a broad range of customers. The company is based in Newport, RI. Entanglement is dedicated to accelerating the development of quantum information science (qis) and artificial intelligence (ai) by aligning its world-class team to an environment that enables customers to rapidly innovate without enormous up-front capital investments. The CEO of the company is Jason Turner. | - |
| John H. Friedman | M | 71 |
Sequella, Inc.
Sequella, Inc. Pharmaceuticals: MajorHealth Technology Sequella, Inc. develops antibiotic drugs resistant to bacterial, fungal, and parasitic infections. It offers product for Mycobacterium tuberculosis, Helicobacter pylori, Clostridium difficile, Nontuberculous mycobacteria, Trypanosomes, and fungal infections. The company was founded by Carol A. Nacy and Leo Einck in 1997 and is headquartered in Rockville, MD. | - |
| Brian Hibbeln | M | - |
Entanglement, Inc.
Entanglement, Inc. Information Technology ServicesTechnology Services Entanglement, Inc. is an early-stage deep technology advanced and quantum computing private company that provides commercial access to diverse advanced computing systems for a broad range of customers. The company is based in Newport, RI. Entanglement is dedicated to accelerating the development of quantum information science (qis) and artificial intelligence (ai) by aligning its world-class team to an environment that enables customers to rapidly innovate without enormous up-front capital investments. The CEO of the company is Jason Turner. | 23 anni |
| Leo Einck | M | - |
Sequella, Inc.
Sequella, Inc. Pharmaceuticals: MajorHealth Technology Sequella, Inc. develops antibiotic drugs resistant to bacterial, fungal, and parasitic infections. It offers product for Mycobacterium tuberculosis, Helicobacter pylori, Clostridium difficile, Nontuberculous mycobacteria, Trypanosomes, and fungal infections. The company was founded by Carol A. Nacy and Leo Einck in 1997 and is headquartered in Rockville, MD. | 27 anni |
| Ronald I. Meltzer | M | - |
Sequella, Inc.
Sequella, Inc. Pharmaceuticals: MajorHealth Technology Sequella, Inc. develops antibiotic drugs resistant to bacterial, fungal, and parasitic infections. It offers product for Mycobacterium tuberculosis, Helicobacter pylori, Clostridium difficile, Nontuberculous mycobacteria, Trypanosomes, and fungal infections. The company was founded by Carol A. Nacy and Leo Einck in 1997 and is headquartered in Rockville, MD. | - |
| Janice Kary | F | - |
Entanglement, Inc.
Entanglement, Inc. Information Technology ServicesTechnology Services Entanglement, Inc. is an early-stage deep technology advanced and quantum computing private company that provides commercial access to diverse advanced computing systems for a broad range of customers. The company is based in Newport, RI. Entanglement is dedicated to accelerating the development of quantum information science (qis) and artificial intelligence (ai) by aligning its world-class team to an environment that enables customers to rapidly innovate without enormous up-front capital investments. The CEO of the company is Jason Turner. | 2 anni |
| Paige MacDonald | F | - |
Sequella, Inc.
Sequella, Inc. Pharmaceuticals: MajorHealth Technology Sequella, Inc. develops antibiotic drugs resistant to bacterial, fungal, and parasitic infections. It offers product for Mycobacterium tuberculosis, Helicobacter pylori, Clostridium difficile, Nontuberculous mycobacteria, Trypanosomes, and fungal infections. The company was founded by Carol A. Nacy and Leo Einck in 1997 and is headquartered in Rockville, MD. | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Irving W. Devoe | M | - |
MR3 Systems, Inc.
 MR3 Systems, Inc. Other Metals/MineralsNon-Energy Minerals MR3 Systems, Inc. provides technology and turnkey solutions for metals-related problem applications and precious metal extraction opportunities. The company has targeted its chelation driven technology to chemically process and separate soluble metals and elements found primarily in mining ores and concentrates, industrial effluents, hazardous wastes, complex metals sources and other aqueous solutions. The company was founded on July 3, 1991 and is headquartered in San Francisco, CA. | - |
| Steven M. Schorr | M | 55 |
MR3 Systems, Inc.
MR3 Systems, Inc. Other Metals/MineralsNon-Energy Minerals MR3 Systems, Inc. provides technology and turnkey solutions for metals-related problem applications and precious metal extraction opportunities. The company has targeted its chelation driven technology to chemically process and separate soluble metals and elements found primarily in mining ores and concentrates, industrial effluents, hazardous wastes, complex metals sources and other aqueous solutions. The company was founded on July 3, 1991 and is headquartered in San Francisco, CA. | 3 anni |
| Merryanawati Anwar | F | 48 |
Point West Capital Corp.
 Point West Capital Corp. Finance/Rental/LeasingFinance Point West Capital Corp. provides financial and lending services. The private company is based in San Francisco, CA and has subsidiaries in the United States. | 2 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 14 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Bradley N. Rotter
- Contatti personali
